Prot#PD0055: A DOSE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF UCB0599 IN STUDY PARTICIPANTS WITH PARKINSON’S DISEASE

Project: Research project

Project Details

StatusActive
Effective start/end date1/26/23 → 1/26/26

Funding

  • Parexel (Prot#PD0055)
  • UCB Biopharma SPRL (Prot#PD0055)